Stoke Therapeutics Inc (STOK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 267,661 | 287,308 | 191,461 | 201,930 | 211,288 |
| Receivables | 6 | 6 | 2 | 9 | 144 |
| Other current assets | 117 | 181 | 378 | 77 | 0 |
| TOTAL | $275,295 | $293,930 | $195,456 | $205,544 | $215,774 |
| Non-Current Assets | |||||
| PPE Net | 2,711 | 2,675 | 2,893 | 2,823 | 2,962 |
| Other Non-Current Assets | 902 | 1,320 | 1,586 | 1,847 | 2,105 |
| TOTAL | $3,613 | $3,995 | $4,479 | $4,670 | $5,067 |
| Total Assets | $278,908 | $297,925 | $199,935 | $210,214 | $220,841 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,496 | 1,495 | 1,095 | 904 | 1,779 |
| Accrued Expenses | 4,614 | 9,930 | 5,640 | 4,901 | 3,676 |
| TOTAL | $6,110 | $11,425 | $6,735 | $5,805 | $5,455 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 333 | 422 | 665 | 1,009 | 1,044 |
| TOTAL | $333 | $422 | $665 | $1,009 | $1,044 |
| Total Liabilities | $6,443 | $11,847 | $7,400 | $6,814 | $6,499 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 36,708 | 36,664 | 33,470 | 33,241 | 32,973 |
| Common Shares | 4 | 4 | 3 | 3 | 3 |
| Retained earnings | -127,071 | -110,278 | -95,717 | -82,033 | -69,074 |
| TOTAL | $272,465 | $286,078 | $192,535 | $203,400 | $214,342 |
| Total Liabilities And Equity | $278,908 | $297,925 | $199,935 | $210,214 | $220,841 |